Buy Max Healthcare; target of Rs 1160: Choice Institutional Equities

Key Investment Pillars

• Max Healthcare's growth is supported by a strong brownfield and greenfield expansion pipeline, with plans to add ~2,500 beds by FY29, driving sustained growth over the next 3-4 years.
• The company's ability to ramp up newly-commissioned capacity provides meaningful earnings visibility, with operating leverage expected to strengthen as new facilities mature.
• Investments in complementary healthcare services, such as international healthcare, diagnostics, and homecare, are anticipated to diversify revenues, expand market presence, and sustain earnings growth over the long term.
• The management's strategy to improve occupancy and expand capacity is expected to drive top-line growth and margin expansion.

Thesis Validation Checklist

• Over the next 12 months, investors should watch for signs of successful capacity expansion, improving occupancy rates, and growth in complementary healthcare services.
• Key signals to validate the thesis include: (1) increasing occupied bed days, (2) improving EBITDA margins, (3) successful commissioning of new facilities, and (4) growth in international healthcare, diagnostics, and homecare services.
• Any significant delays or setbacks in the expansion plans, or failure to improve occupancy rates, could challenge the investment thesis.